Shanghai Hile Bio-Technology Co., Ltd. (603718.SS)
CNY 7.11
(0.0%)
CNY 7.11
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 68.54 Million CNY | 13.23% |
| 2022 | 101.95 Million CNY | -34.61% |
| 2021 | 155.92 Million CNY | 18.11% |
| 2020 | 132.01 Million CNY | 0.14% |
| 2019 | 131.83 Million CNY | -4.34% |
| 2018 | 137.81 Million CNY | -1.96% |
| 2017 | 140.56 Million CNY | -28.34% |
| 2016 | 196.15 Million CNY | 34.84% |
| 2015 | 145.47 Million CNY | 16.41% |
| 2014 | 124.96 Million CNY | 4.29% |
| 2013 | 119.82 Million CNY | 1.91% |
| 2012 | 117.57 Million CNY | 36.79% |
| 2011 | 85.95 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 38.15 Million CNY | -4.58% |
| 2024 Q3 | 44.91 Million CNY | 33.64% |
| 2024 Q2 | 32.45 Million CNY | -14.94% |
| 2023 Q1 | 30.81 Million CNY | 216.27% |
| 2023 FY | 115.44 Million CNY | 13.23% |
| 2023 Q2 | 20.34 Million CNY | -33.98% |
| 2023 Q4 | 39.98 Million CNY | 64.58% |
| 2023 Q3 | 24.29 Million CNY | 19.42% |
| 2022 Q3 | 45.41 Million CNY | -3.66% |
| 2022 FY | 101.95 Million CNY | -34.61% |
| 2022 Q4 | -26.5 Million CNY | -158.36% |
| 2022 Q1 | 35.9 Million CNY | -19.46% |
| 2022 Q2 | 47.14 Million CNY | 31.28% |
| 2021 FY | 155.92 Million CNY | 18.11% |
| 2021 Q1 | 39.53 Million CNY | 37.87% |
| 2021 Q2 | 33.94 Million CNY | -14.14% |
| 2021 Q3 | 37.86 Million CNY | 11.53% |
| 2021 Q4 | 44.58 Million CNY | 17.75% |
| 2020 Q4 | 28.67 Million CNY | -25.59% |
| 2020 Q1 | 20.51 Million CNY | -57.14% |
| 2020 Q3 | 38.53 Million CNY | -12.99% |
| 2020 Q2 | 44.29 Million CNY | 115.94% |
| 2020 FY | 132.01 Million CNY | 0.14% |
| 2019 Q1 | 29.89 Million CNY | -11.01% |
| 2019 FY | 131.83 Million CNY | -4.34% |
| 2019 Q2 | 28.6 Million CNY | -4.31% |
| 2019 Q4 | 47.86 Million CNY | 87.82% |
| 2019 Q3 | 25.48 Million CNY | -10.92% |
| 2018 Q1 | 24.6 Million CNY | 40.76% |
| 2018 FY | 137.81 Million CNY | -1.96% |
| 2018 Q4 | 33.59 Million CNY | -24.49% |
| 2018 Q3 | 44.48 Million CNY | 26.61% |
| 2018 Q2 | 35.13 Million CNY | 42.81% |
| 2017 Q1 | 37.57 Million CNY | -39.6% |
| 2017 FY | 140.56 Million CNY | -28.34% |
| 2017 Q4 | 17.47 Million CNY | -61.93% |
| 2017 Q3 | 45.91 Million CNY | 15.95% |
| 2017 Q2 | 39.59 Million CNY | 5.38% |
| 2016 Q2 | 44.41 Million CNY | 45.53% |
| 2016 FY | 196.15 Million CNY | 34.84% |
| 2016 Q3 | 59 Million CNY | 32.83% |
| 2016 Q1 | 30.52 Million CNY | -30.34% |
| 2016 Q4 | 62.2 Million CNY | 5.43% |
| 2015 Q1 | 23.39 Million CNY | -24.01% |
| 2015 FY | 145.47 Million CNY | 16.41% |
| 2015 Q4 | 43.81 Million CNY | 4.82% |
| 2015 Q3 | 41.8 Million CNY | 14.64% |
| 2015 Q2 | 36.46 Million CNY | 55.83% |
| 2014 FY | 124.96 Million CNY | 4.29% |
| 2014 Q3 | 26.72 Million CNY | -34.21% |
| 2014 Q1 | 26.82 Million CNY | 0.0% |
| 2014 Q2 | 40.62 Million CNY | 51.43% |
| 2014 Q4 | 30.79 Million CNY | 15.21% |
| 2013 FY | 119.82 Million CNY | 1.91% |
| 2012 FY | 117.57 Million CNY | 36.79% |
| 2011 FY | 85.95 Million CNY | 0.0% |